Imagine The Future: Enhanced Oligonucleotide Synthesis

By Lucy Cook, Ph.D. Senior Global Marketing Manager for Nucleic Acid Therapeutics

With the right software, even a chemist lacking experience in oligonucleotide synthesis can feel confident their first attempt will be successful. The introduction of UNICORN™ 7 software has revolutionized the way that method creation, evaluation, and process optimizations for scale-up are completed. Utilizing the newly introduced phases within this software, users gain access to pre-established and validated instructions, enabling the creation of synthesis methods with a high probability of success. Despite this automated support, users retain control over critical parameters such as the intended scale, column selection, solid support type, required packing density, and specific sequence to be synthesized. Continue reading to learn more about this flexible software for enhanced oligonucleotide synthesis.